ecmo
form
mechan
cardiopulmonari
support
provid
prolong
extracorpor
life
support
patient
unrespons
convent
manag
two
form
ecmo
venoven
vv
typic
use
case
sever
respiratori
failur
venoarteri
va
venovenousarteri
vva
patient
cardiogen
shock
vv
ecmo
blood
extract
vena
cava
right
atrium
return
right
atrium
form
ecmo
provid
respiratori
support
hemodynam
support
use
patient
acut
respiratori
failur
replac
ga
exchang
function
lung
ecmo
facilit
protect
mechan
ventil
oxygen
carbon
dioxid
clearanc
provid
extracorpor
circuit
decreas
magnitud
ventilatorinduc
lung
injuri
secondari
volutrauma
barotrauma
oxygen
toxic
va
ecmo
vva
ecmo
provid
respiratori
hemodynam
support
use
patient
cardiogen
shock
cardiac
arrest
va
ecmo
blood
extract
right
atrium
return
arteri
system
thu
bypass
heart
lung
ecmo
therapi
associ
potenti
sever
side
effect
includ
bleed
vascular
complic
increas
risk
nosocomi
infect
poor
neurolog
outcom
va
ecmo
particular
provid
hemodynam
support
reduc
left
ventricular
afterload
exacerb
pulmonari
congest
patient
exhibit
system
inflammatori
respons
syndrom
due
exposur
patient
blood
nonendotheli
surfac
ecmo
circuit
potenti
concern
system
inflammatori
respons
syndrom
ecmo
detriment
recoveri
process
patient
lymphopenia
rais
report
poor
prognost
indic
patient
suggest
monitor
lymphocyt
count
prognost
marker
could
use
treat
ecmo
ecmo
therapi
use
rescu
therapi
critic
patient
therefor
select
bia
use
patient
outset
signific
morbid
mortal
patient
select
ecmo
judici
optim
patient
outcom
reassur
result
cesar
trial
convent
ventilatori
support
vs
extracorpor
membran
oxygen
sever
adult
respiratori
failur
success
use
ecmo
sever
ard
case
influenza
pandem
led
exponenti
use
vv
ecmo
acut
respiratori
failur
last
decad
ecmo
provid
full
blood
oxygen
carbon
dioxid
elimin
allow
lung
rest
enabl
lowvolum
lowpressur
ventil
consid
reason
therapeut
option
support
patient
sever
acut
lung
injuri
refractori
convent
measur
approach
support
berlin
consensu
document
ard
shortterm
mechan
circulatori
assist
devic
va
ecmo
use
bridg
therapi
recoveri
cardiogen
shock
provid
respiratori
cardiac
support
improv
endorgan
perfus
reduc
fill
volum
augment
coronari
perfus
howev
outcom
vaecmo
refractori
cardiogen
shock
poor
overal
report
surviv
rate
consider
better
prognosi
case
fulmin
myocard
predict
tool
surviv
venoarteri
ecmo
score
develop
assist
predict
patient
cardiogen
shock
may
higher
chanc
surviv
ecmo
therapi
extracorpor
life
support
organis
registri
ongo
registri
patient
ecmo
support
data
adult
patient
viral
pneumonia
caus
show
overal
surviv
averag
durat
ecmo
use
day
influenza
pandem
almost
third
patient
admit
intens
care
unit
icu
support
ecmo
therapi
variou
case
seri
report
trend
toward
decreas
mortal
receiv
ecmo
therapi
italian
cohort
report
surviv
hospit
discharg
patient
receiv
ecmo
influenza
pandem
avian
influenza
viral
pneumonia
manifest
vari
degre
dyspnea
patient
develop
ard
subsequ
high
mortal
rate
review
patient
ecmo
use
ard
patient
avian
influenza
ventil
paramet
patient
ecmo
includ
tidal
volum
significantli
decreas
physiolog
paramet
ph
significantli
improv
inhospit
mortal
cohort
middl
east
respiratori
syndrom
mer
caus
coronaviru
merscov
character
respiratori
failur
associ
high
mortal
rate
diseas
primarili
seen
middl
east
peak
retrospect
analysi
merscov
patient
icu
refractori
respiratori
failur
treat
ecmo
significantli
lower
inhospit
mortal
vs
p
compar
receiv
convent
therapi
also
associ
longer
icu
stay
vs
day
p
patient
die
five
die
due
uncontrol
hemorrhag
nine
septic
shock
highlight
potenti
fatal
complic
ecmo
therapi
report
recent
publish
describ
clinic
characterist
sever
diseas
recent
report
wuhan
china
publish
lancet
report
cohort
six
patient
case
icu
receiv
ecmo
one
patient
surviv
anoth
report
wuhan
china
publish
jama
patient
admit
icu
four
patient
treat
ecmo
letter
jama
describ
characterist
outcom
critic
ill
patient
washington
state
usa
acut
cardiomyopathi
report
seven
patient
cohort
still
unknown
due
acut
viral
myocard
due
overwhelm
ill
data
far
report
high
rate
potenti
fatal
complic
howev
clinic
cours
outcom
patient
yet
report
benefit
ecmo
yet
determin
societi
critic
care
medicin
releas
tent
guidelin
manag
patient
guidelin
recommend
vv
ecmo
manag
ard
refractori
hypoxemia
persist
despit
optim
ventil
use
rescu
therapi
use
inhal
pulmonari
vasodil
prone
provid
algorithm
help
guid
decisionmak
follow
criteria
promot
recommend
earli
ecmo
usag
mmhg
h
mmhg
h
ph
mmhg
h
current
weak
recommend
lowqual
evid
howev
come
import
caveat
ecmo
resourceintens
therapi
current
pandem
wave
new
case
ecmo
consid
good
prognosi
without
signific
comorbid
less
day
mechan
ventil
consid
critic
ill
elderli
due
poor
outcom
regardless
ecmo
support
furthermor
ecmo
use
resourcest
center
set
person
protect
equip
staff
limit
wake
extracorpor
membran
oxygen
novel
coronaviru
acut
respiratori
diseas
studi
conduct
hope
extrem
import
registri
give
us
insight
role
ecmo
diseas
lancet
publish
document
regard
plan
ecmo
prepared
provis
pandem
high
transmiss
rate
sever
acut
respiratori
syndrom
ardsrel
mortal
sweep
world
number
patient
may
need
special
support
current
unknown
also
unknown
abil
nation
healthcar
system
provid
special
therapi
resourcestrain
pandem
conclus
ecmo
resourceintens
form
life
support
use
rescu
therapi
critic
patient
ecmo
could
use
patient
sever
ard
cardiomyopathi
convent
therapi
fail
number
patient
might
requir
level
support
current
unknown
data
need
